Navigation Links
Reusable Template

ProductsReusable Template
Company Mick Radio-Nuclear Instruments, Inc.
Item Reusable Template
Features 
  • The Reusable Template consists of rows and columns of holes spaced 5mm apart and labeled to match the ultrasound software.
  • The holes will accept needles of specified diameter.
Description The Reusable Template is designed for use with the Brachystepper® as a guidance system for prostate brachytherapy. Please be sure that the graphics on your software match the graphics on the Reusable Template. Reusable Template with two pins protruding from lower surface which fits into the Reusable Template mount on the Brachystepper®.
Info Mick Radio-Nuclear Instruments, Inc.
Customer Service: (877) 597-6764
Web site: http://www.micknuclear.com

Related medicine products :

1. Reusable Electrodes
2. Reusable Bipolar Forceps
3. Mayfield Reusable Adult Skull Pins
4. Mayfield Reusable Child Skull Pins
5. Gardener Reusable Child Skull Pins
6. Gardener Reusable Adult Skull Pins
7. Ophth. Laser Endoscope - Autoclavable, Reusable
8. Ophth. Laser Endoscope - Curved, Autoclavable, Reusable
9. Endophotocoagulation Probe, Fully Reusable, Autoclavable
10. Illuminated Laser Probe, Wide Field, Fully Reusable, Autoclavable
11. Wide Field Illumination Probe, Fully Reusable, Autoclavable
A sophisticated research tool that allows to see the fundus picture of the area which is being stimulated. Besides it also includes the refractive pupil camera enabling the examiner to switch between
The only air-based esthesiometer with a database of normal sensation on the cornea. May have application to the measurement of normal-tension glaucoma.
Kelly Punches
... instrument provides standardized glare testing. I...ces for the evaluation of glare disability. For ca...ecisely calibrated to simulate two on-coming halog...The glare level can be adjusted to simulate other ...
Medicine Products:
(Date:9/7/2008)...s also been linked recently to patient deaths , ...w once-a-week formulation of the injectable diabet...an the older twice-a-day formulation, researchers ..., [the new formulation] provided the remarkable ad...ol and good gastrointestinal tolerability," said D...
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Lieuten...proclamation acknowledging Sept. 11 as,American Re...nsylvania and The American Red Cross ask donors,of... those who lost their,lives on 9/11 and to help st...ion can save up to three lives., "We all remember...
(Date:9/5/2008)...xplain how theoretical ,anti-cloak, could bring ob...(HealthDay News) -- Just in case someone develops ...sts say they know how to uncloak the objects it hi...s Express , certain materials underneath an invisi...een again. , Researchers at Shanghai Jiao Tong ...
(Date:9/5/2008)... Mass., Sept. 5 /PRNewswire/ -- Arthrosurface, Inc...of less-invasive joint,resurfacing systems, announ...A to begin its pivotal investigation for its line ... that "there are no outstanding safety,concerns" w... Arthrosurface has been evaluating the safety and ...
Breaking Medicine News(10 mins):Health News:Once-Weekly Diabetes Drug Boosts Blood Sugar Control 2Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2
...urvey suggests that approximately 50% of the publi...t of a bird flu pandemic. // A majority of these p...al support staff. More than 308 public health wor... which nearly 46.2% expressed that they would not ...
...hrough a study by neuroscientists at Harvard Medic...ong-term exposure to stress hormone in mice direct... depression. April issue of Behavioral Neuroscienc...Psychological Association, has this article. This...
...sychological Science says that children's habits a...cially true in determining if a child would be an ...ld as clay to be molded,” said Phillip Dale, profe...nce and Disorders Department in the School of Heal...
...onducted by drug researchers has revealed that ena...inmates who are addicted to heroin, //would serve ...ffence and the cost of locking up prisoners for a ...onal Health and Medical Research Council sponsored...
Other Medicine News:Health News:Bird Flu Pandemic Study: Clerical & Support Staff May Stay At Home 2Health News:Link Between Stress Hormone And Depression Revealed 2Health News:Cost-Benefit Economics of Methadone for prisoners 2
(Date:9/8/2008)...t. 8 /- Medarex, Inc.,(Nasd...estone payment for an,undisclosed amount from its ... payment is a result of the submission of an Inves...r the clinical development of an antibody,generate...receive future,milestone payments and royalties sh...
(Date:9/6/2008)...ety and Efficacy of First-in-Class Neurally Acting...of Acute Migraine, LONDON, Sept. 6 /...technology company focusing on therapies for centr...sults of its lead compound COL-144,in the treatmen...-144 was,safe and effective in relieving migraine ...
(Date:9/5/2008)... Calif., Sept. 5 /- SARcode...olecule LFA-1 inhibitors,to treat inflammatory dis...SNSS) today announced SARcode,s initiation of a Ph...duct candidate for T-cell mediated ophthalmic,dise...greement providing,SARcode with an exclusive licen...
(Date:9/4/2008)...ept. 4 /- BioForm Medical,...otal clinical study of,Polidocanol, conducted in G...rik KREUSSLER & Co. GmbH (Kreussler), successfully...tted to FDA as part of a New Drug Application,(NDA...the EASI (Efficacy and safety of,Aethoxysklerol co...
Breaking Medicine Technology:Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing 2Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing 3Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Pharmasset Appoints Michael Rogers as Chief Development Officer 1664 1Pharmasset Appoints Michael Rogers as Chief Development Officer 1664 2Pharmasset Appoints Michael Rogers as Chief Development Officer 1664 3Renovis to Present at CIBC World Markets Healthcare Conference 1661 1Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7 2007 1658 1Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7 2007 1658 2Pharmacopeia Announces Third Quarter 2007 Financial Results 727 1Pharmacopeia Announces Third Quarter 2007 Financial Results 727 2Pharmacopeia Announces Third Quarter 2007 Financial Results 727 3Pharmacopeia Announces Third Quarter 2007 Financial Results 727 4Pharmacopeia Announces Third Quarter 2007 Financial Results 727 5Pharmacopeia Announces Third Quarter 2007 Financial Results 727 6Pharmacopeia Announces Third Quarter 2007 Financial Results 727 7Pharmacopeia Announces Third Quarter 2007 Financial Results 727 8Pharmacopeia Announces Third Quarter 2007 Financial Results 727 9Pharmacopeia Announces Third Quarter 2007 Financial Results 727 10Pharmacopeia Announces Third Quarter 2007 Financial Results 727 11
...nical Studies Suggest FTY720 Mechanisms in Multipl...in , · Preclinical studies suggest FTY720 s...tion and enhance repair of the,CNS affected by mul...om the six-month multiple,sclerosis Phase II clini...th clinical depression was significantly lower in ...
... Conference Call Scheduled for Friday, May 4, at 9...CO, May 03, 2007 /PRNewswire-FirstCall/ --,Medivat...ild and,moderate subgroups of Alzheimer,s disease ...cy study of Dimebon showed that both,subgroups wer...on,all five efficacy endpoints studied. , The mean...
Other Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5